Pfizer boosts profit estimate, even as the drug giant absorbs tariffs

by | Aug 5, 2025 | Stock Market

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

Article Attribution | Read More at Article Source